Sight Diagnostics For Profit
Sight Diagnostics is a medical platform that specializes in diagnosing blood diseases using digital fluorescent microscopy. Their technology combines machine vision and AI to provide fast, convenient, and accurate diagnostics. Their first product, Parasight, has successfully diagnosed malaria in close to 1 million tests across 24 countries. Their latest product, Sight OLO, is an FDA 510(k) cleared blood analyzer that can provide lab-grade Complete Blood Count results in minutes using only 2 drops of a finger prick or venous sample. With offices in the UK, the US, and Israel, Sight Diagnostics has a global presence and is revolutionizing blood diagnostics.
Investors
Funding Status:
Late Stage Venture
Headquarters:
Tel Aviv, Tel Aviv, Israel
Founded Date:
2011
Employee Number:
130
Last Funding Type:
Series D
Total Funding:
123800000
Estimated Revenue:
$1M to $10M
Industry:
Deep Diagnostics
Investors Number:
12
Technology:
Biomarker panels
Investor Type:
Company
Last Funding Date:
2020
Number Of Exists:
N/A
Investment Stage:
N/A